2025. The 40-Gene Expression Profile Test Identifies Patients with National Comprehensive Cancer Network High-Risk Cutaneous Squamous Cell Carcinoma at High Risk of Poor Outcomes to Inform Management Decisions. SKIN The Journal of Cutaneous Medicine. 9, 4 (Jul. 2025), 2426–2443. DOI:https://doi.org/10.25251/mvr2rn83.